Clinical trial
Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain
NCT00433290 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00433290 |
|---|---|
| Title | Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain |
| Official title | Protocol F1J-MC-HMFG Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis Knee Pain |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 256 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Feb 9, 2007 |
| Last update posted | Sep 2, 2009 |
| Countries | Greece, Russia, Sweden, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: